Jpmorgan Chase & CO Tango Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 52,840 shares of TNGX stock, worth $160,633. This represents 0.0% of its overall portfolio holdings.

Number of Shares

52,840

Previous 51,559 2.48%

Holding current value

$160,633

Previous $442,000 8.14%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$7.36 - $11.93 $9,428 - $15,282	1,281 Added 2.48%	52,840 $406,000
Q2 2024 Aug 12, 2024	SELL	$6.66 - $10.15 $473,779 - $722,050	-71,138 Reduced 57.98%	51,559 $442,000
Q1 2024 May 10, 2024	BUY	$7.51 - $12.88 $547,433 - $938,874	72,894 Added 146.36%	122,697 $974,000
Q4 2023 Feb 12, 2024	BUY	$6.52 - $12.01 $16,632 - $30,637	2,551 Added 5.4%	49,803 $493,000
Q3 2023 Nov 14, 2023	BUY	$2.93 - $11.26 $22,338 - $85,846	7,624 Added 19.24%	47,252 $532,000
Q2 2023 Aug 11, 2023	SELL	$2.67 - $4.7 $56,980 - $100,302	-21,341 Reduced 35.0%	39,628 $131,000
Q1 2023 May 18, 2023	BUY	$3.76 - $8.06 $213,436 - $457,525	56,765 Added 1350.26%	60,969 $240,000
Q1 2023 May 11, 2023	SELL	$3.76 - $8.06 $172,151 - $369,027	-45,785 Reduced 91.59%	4,204 $16,000
Q4 2022 Feb 13, 2023	BUY	$3.41 - $8.29 $27,736 - $67,430	8,134 Added 19.43%	49,989 $363,000
Q3 2022 Nov 14, 2022	SELL	$3.25 - $5.46 $24,284 - $40,797	-7,472 Reduced 15.15%	41,855 $151,000
Q2 2022 Aug 11, 2022	BUY	$3.86 - $8.01 $89,127 - $184,950	23,090 Added 88.01%	49,327 $224,000
Q1 2022 May 11, 2022	SELL	$7.01 - $10.94 $44,148 - $68,900	-6,298 Reduced 19.36%	26,237 $199,000
Q4 2021 Feb 10, 2022	BUY	$9.55 - $14.29 $293,404 - $439,031	30,723 Added 1695.53%	32,535 $357,000
Q3 2021 Nov 12, 2021	BUY	$9.56 - $17.3 $17,322 - $31,347	1,812 New	1,812 $23,000

Others Institutions Holding TNGX

# of Institutions

123

Shares Held

91.7M

Call Options Held

3.1K

Put Options Held

1.5K

View Full List

About Tango Therapeutics, Inc.

Ticker TNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,067,296
Market Cap $268M
Description
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...

More about TNGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Tango Therapeutics, Inc. Transaction History